Rifampicin - A new antitrachoma drug

Yechiel Becker*, Zichriya Zakay-Rones

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

Trachoma agent is sensitive to rifampicin early in its growth cycle, both in infected cells in vitro and in embryonated eggs in vivo.

Original languageEnglish
Pages (from-to)851-853
Number of pages3
JournalNature
Volume222
Issue number5196
DOIs
StatePublished - 1969

Fingerprint

Dive into the research topics of 'Rifampicin - A new antitrachoma drug'. Together they form a unique fingerprint.

Cite this